Using DNA and hemoglobin adducts to improve the risk assessment of butadiene.
The purpose of this paper is to review what we know about various biomarkers of butadiene in animal, human and in vitro studies, and to draw inferences from these data that impact on the accurate assessment of human risks for cancer. Studies comparing the DNA and hemoglobin adducts of butadiene with exposure, metabolism and genotoxicity have provided a great deal of insight that is applicable to biologically based risk assessment. First, the DNA and hemoglobin adduct data strongly support the conclusion that 3,4-epoxy-1,2-butanediol is the major electrophile available for binding to these macromolecules. Biomarker studies have also provided insight into the possibility of a sensitive population associated with the GSTT1 null genotype. While it is clear that lymphocytes from GSTT1 null individuals are more sensitive for the induction of sister chromatid exchanges (SCE) following in vitro exposure to 1,2,3,4-diepoxybutane, there was no such increase in SCE or other biomarkers of genotoxicity in workers exposed to 1-3 p.p.m. butadiene, regardless of GST genotype. The globin adduct data also demonstrate that there is roughly a tenfold range for interindividual differences in the metabolism of butadiene. This type of analysis represents an excellent means for providing scientific data for this critical determinant. Another useful application of hemoglobin adducts in risk assessment was demonstrated by regressing data for various endpoints for genotoxicity against that individual's biologically effective dose, thereby providing an independent mechanism for evaluation that excludes any possible confounding by inappropriate controls. Finally, biomarker studies have identified critical gaps in our knowledge that are needed for the accurate assessment of butadiene. Most notable of these is the lack of diepoxide-specific biomarkers in mice, rats and humans.
Swenberg
J A
JA
Laboratory of Molecular Carcinogenesis and Mutagenesis, Department of Environmental Sciences and Engineering, CB# 7400, University of North Carolina, Chapel Hill, NC 27599-7400, USA. james_swenberg@unc.edu
Koc
H
H
Upton
P B
PB
Georguieva
N
N
Ranasinghe
A
A
Walker
V E
VE
Henderson
R
R
D000818:Animals; D015415:Biomarkers; D002070:Butadienes / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity*; D018736:DNA Adducts / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D006454:Hemoglobins / Q000737:chemistry / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D009153:Mutagens / Q000737:chemistry / Q000378:metabolism / Q000633:toxicity; D018570:Risk Assessment
D015415:Biomarkers; D002070:Butadienes; D018736:DNA Adducts; D006454:Hemoglobins; D009153:Mutagens; C031763:1,3-butadiene